Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención
Background: Neuropathy is a common complication of diabetic patients. Aim: To determine the prevalence of diabetic peripheral neuropathy in Type 2 diabetic patients attended at a family medicine unit. Material and Methods: Cross-sectional assessment of 348 type 2 diabetic patients aged 34-89 years (...
Guardado en:
Autores principales: | , , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2012
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000900004 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872012000900004 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720120009000042013-01-02Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atenciónIbarra R,Carlos TomásRocha L,José de JesúsHernández O,RaúlNieves R,Rene EfrénLeyva J,Rafael Diabetes mellitus, type 2 Diabetic neuropathies Diagnostic techniques neurological Prevalence Michigan Neuropathy Screening Instrument Background: Neuropathy is a common complication of diabetic patients. Aim: To determine the prevalence of diabetic peripheral neuropathy in Type 2 diabetic patients attended at a family medicine unit. Material and Methods: Cross-sectional assessment of 348 type 2 diabetic patients aged 34-89 years (60% females) with a disease duration of 5 to 15 years. Peripheral neurological status was evaluated using The Michigan Neuropathy Screening Instrument, a tool that includes a self-assessment of symptoms and a physical examination. Results: Diabetic neuropathy was found in 240patients (69%). The prevalence in males and females was 72 and 67% respectively. The prevalence in patients with a disease duration of 5, 10 and 15 years, was 59, 69 and 77%, respectively. Fifty percent of patients with neuropathy complained of dry skin, 2% had ulcers, 43% had an abnormal perception of vibration and 29% had an abnormal monofilament test. Conclusions: The overall prevalence of peripheral neuropathy in this group of patients was 69% and was directly associated with the duration of the disease.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.140 n.9 20122012-09-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000900004es10.4067/S0034-98872012000900004 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Diabetes mellitus, type 2 Diabetic neuropathies Diagnostic techniques neurological Prevalence Michigan Neuropathy Screening Instrument |
spellingShingle |
Diabetes mellitus, type 2 Diabetic neuropathies Diagnostic techniques neurological Prevalence Michigan Neuropathy Screening Instrument Ibarra R,Carlos Tomás Rocha L,José de Jesús Hernández O,Raúl Nieves R,Rene Efrén Leyva J,Rafael Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención |
description |
Background: Neuropathy is a common complication of diabetic patients. Aim: To determine the prevalence of diabetic peripheral neuropathy in Type 2 diabetic patients attended at a family medicine unit. Material and Methods: Cross-sectional assessment of 348 type 2 diabetic patients aged 34-89 years (60% females) with a disease duration of 5 to 15 years. Peripheral neurological status was evaluated using The Michigan Neuropathy Screening Instrument, a tool that includes a self-assessment of symptoms and a physical examination. Results: Diabetic neuropathy was found in 240patients (69%). The prevalence in males and females was 72 and 67% respectively. The prevalence in patients with a disease duration of 5, 10 and 15 years, was 59, 69 and 77%, respectively. Fifty percent of patients with neuropathy complained of dry skin, 2% had ulcers, 43% had an abnormal perception of vibration and 29% had an abnormal monofilament test. Conclusions: The overall prevalence of peripheral neuropathy in this group of patients was 69% and was directly associated with the duration of the disease. |
author |
Ibarra R,Carlos Tomás Rocha L,José de Jesús Hernández O,Raúl Nieves R,Rene Efrén Leyva J,Rafael |
author_facet |
Ibarra R,Carlos Tomás Rocha L,José de Jesús Hernández O,Raúl Nieves R,Rene Efrén Leyva J,Rafael |
author_sort |
Ibarra R,Carlos Tomás |
title |
Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención |
title_short |
Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención |
title_full |
Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención |
title_fullStr |
Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención |
title_full_unstemmed |
Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención |
title_sort |
prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención |
publisher |
Sociedad Médica de Santiago |
publishDate |
2012 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000900004 |
work_keys_str_mv |
AT ibarrarcarlostomas prevalenciadeneuropatiaperifericaendiabeticostipo2enelprimerniveldeatencion AT rochaljosedejesus prevalenciadeneuropatiaperifericaendiabeticostipo2enelprimerniveldeatencion AT hernandezoraul prevalenciadeneuropatiaperifericaendiabeticostipo2enelprimerniveldeatencion AT nievesrreneefren prevalenciadeneuropatiaperifericaendiabeticostipo2enelprimerniveldeatencion AT leyvajrafael prevalenciadeneuropatiaperifericaendiabeticostipo2enelprimerniveldeatencion |
_version_ |
1718436646958923776 |